Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes
Completed
Merck Sharp & Dohme Corp.
Phase 3
The purpose of this study is to learn more about how muraglitazar lowers blood sugar in
people with type 2 diabetes. The safety of this treatment will also be studied.
Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes
Completed
Bristol-Myers Squibb
Phase 3
The purpose of this study is to learn more about how muraglitazar lowers blood sugar in
people with type 2 diabetes. The safety of this treatment will also be studied.
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
Completed
Merck Sharp & Dohme Corp.
Phase 3
The purpose of this clinical research study is to learn whether a muraglitazar-metformin
combination is at least as effective as a glimepiride-metformin combination to treat type 2
diabetics who are not sufficiently controlled with metformin alone. The safety of this
treatment will also be studied.
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
Completed
Bristol-Myers Squibb
Phase 3
The purpose of this clinical research study is to learn whether a muraglitazar-metformin
combination is at least as effective as a glimepiride-metformin combination to treat type 2
diabetics who are not sufficiently controlled with metformin alone. The safety of this
treatment will also be studied.
Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
Completed
Merck Sharp & Dohme Corp.
Phase 3
The purpose of this study is to compare Muraglitazar and Pioglitazone in patients with Type 2
Diabetes. Both the safety and blood sugar lowering effects of these treatments will be
studied.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
